Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;54(1):27-40.
doi: 10.1080/10409238.2019.1568963. Epub 2019 Feb 4.

A Tumor Suppressive DNA Translocase Named FANCM


A Tumor Suppressive DNA Translocase Named FANCM

Jihane Basbous et al. Crit Rev Biochem Mol Biol. .


FANCM is named after Fanconi anemia (FA) complement group M. The clinical symptoms of FA include congenital abnormalities, pancytopenia, and cancer proneness. However, recent studies reveal that biallelic inactivation of FANCM does not cause the constellation of FA symptoms, but predisposes patients to cancer and infertility. FANCM is a tumor suppressor gene that encodes a conserved and structure-specific DNA translocase. It controls the outcome of homologous recombination and facilitates DNA replication across a variety of natural and chemically induced obstacles. This review details our current understanding of FANCM as a facilitator of the cellular functions of caretaker proteins, including FA, Bloom syndrome, and Ataxia telangiectasia and RAD3-related proteins, which collectively ensure the maintenance of chromosome stability during DNA replication.

Keywords: FANCM; Fanconi anemia; cancer; chromosome instability; replication forks.

Similar articles

See all similar articles

Cited by 3 articles

Publication types

LinkOut - more resources